Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer

ClinicalTrials.gov ID: NCT00062426

Public ClinicalTrials.gov record NCT00062426. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Prospective Study Comparing Three Regimens Of Eloxatin ™ Plus Fluoropyrimidine For Evaluation Of Safety And Tolerability In First Line Treatment Of Patients With Advanced Colorectal Cancer (Tree Study)

Study identification

NCT ID
NCT00062426
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Prologue Research International
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • bevacizumab Biological
  • capecitabine Drug
  • fluorouracil Drug
  • leucovorin calcium Drug
  • oxaliplatin Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Not listed
Completion
Jan 31, 2011
Last update posted
Nov 5, 2013

2003 – 2011

United States locations

U.S. sites
52
U.S. states
27
U.S. cities
50
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Arizona Clinical Research Center Tucson Arizona 85712
California Cancer Care, Inc. Greenbrae California 94904-2007
Valley Tumor Medical Group Lancaster California 93534
Cancer and Blood Institute of the Desert Rancho Mirage California 92270
Rocky Mountain Cancer Centers - Midtown Denver Colorado 80218
Northwestern Connecticut Oncology-Hematology Associates Torrington Connecticut 06790
Lombardi Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007
Lynn Regional Cancer Center West Boca Raton Florida 33428
Florida Cancer Specialists Fort Myers Florida 33901
Florida Oncology Associates Jacksonville Florida 32207
Hematology and Oncology Consultants, P.A. Orlando Florida 32804
Hematology Oncology Associates of theTreasure Coast - Port St. Lucie Port Saint Lucie Florida 34952
Palm Beach Cancer Institute West Palm Beach Florida 33401
Peachtree Hematology and Oncology Consultants, P.C. Atlanta Georgia 30309
North Idaho Cancer Center Coeur d'Alene Idaho 83814
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611
Lutheran General Cancer Care Center Park Ridge Illinois 60068-1270
West Suburban Center for Cancer Care River Forest Illinois 60305
Saint Anthony Medical Center Rockford Illinois 61108
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Cedar Rapids Oncology Associates Cedar Rapids Iowa 52403-1206
CCOP - Wichita Wichita Kansas 67214-3882
Greater Baltimore Medical Center and Cancer Center Baltimore Maryland 21204
Jackson Oncology Associates, PLLC Jackson Mississippi 39202
Veterans Affairs Medical Center - Kansas City Kansas City Missouri 64128
Deaconess Billings Clinic Cancer Center Billings Montana 59107-5100
Cooper Cancer Institute at Cooper University Hospital Voorhees Township New Jersey 08043
Advanced Oncology Associates Armonk New York 10504
North Shore Hematology/Oncology Associates, P.C. East Setauket New York 11733
Arena Oncology Associates Great Neck New York 11021
St. Vincents Comprehensive Cancer Center New York New York 10011
New York University Medical Center New York New York 10016
New York Medical College Valhalla New York 10595
Duke Comprehensive Cancer Center Durham North Carolina 27710
Southeastern Medical Oncology Center Goldsboro North Carolina 27534
Physicians East - Quadrangle Greenville North Carolina 27834
Raleigh Hematology/Oncology Associates, P.A. - Wake Practice Raleigh North Carolina 27609-7300
Hematology Oncology Consultants Inc Columbus Ohio 43235
Hematology/Oncology of Salem Salem Oregon 97301
Pennsylvania Oncology Hematology Associates Philadelphia Pennsylvania 19106
Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232
Charleston Hematology-Oncology, P.A. Charleston South Carolina 29403
McCleod Cancer and Blood Center Johnson City Tennessee 37604
Memphis Cancer Center Memphis Tennessee 38119
West Clinic Memphis Tennessee 38120
Sarah Cannon Cancer Center at Centennial Medical Center Nashville Tennessee 37203
Lone Star Oncology Austin Texas 78759
Medical City Dallas Hospital Dallas Texas 75230
South Texas Oncology and Hematology San Antonio Texas 78207
Center for Cancer Prevention and Care at Scott and White Clinic Temple Texas 76508
Medical Consultants Milwaukee Wisconsin 53215-3690

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00062426, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2013 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00062426 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →